Philips has agreed to a $1.1 billion settlement to resolve personal injury claims related to its recalled CPAP, BiPAP, and ventilator devices. The recall was initiated due to the degradation of sound-abatement foam, which could release harmful particles and gases into the device’s airflow, potentially leading to serious health issues such as respiratory problems and certain cancers.
The settlement process is structured to compensate affected individuals based on the severity of their injuries and the extent of their exposure to the defective devices. Payouts are expected to commence in 2025, with initial payments ranging from $7,500 to $10,000 for less severe cases. More severe cases, such as those involving lung cancer or significant pulmonary conditions, may receive higher compensation, potentially exceeding $100,000, depending on individual circumstances and documentation provided.
In addition to the personal injury settlement, Philips has also agreed to a separate $479 million class-action settlement to address economic losses suffered by users of the recalled devices. This includes compensation for the cost of purchasing or leasing the defective machines and related expenses.